SEATTLE–(BUSINESS WIRE)–$CMI #BloodGasAnalyzersMarket–According to Coherent Market Insights, the global blood gas analyzers
market was valued at US$ 594.6 million in 2017, and is projected to
exhibit a CAGR of 5.5% over the forecast period (2018 – 2026).
Key Trends and Analysis of the Blood Gas Analyzers Market:
Market players are focused on developing cost-effective, easy-to-use
blood gas analyzers, which deliver reliable and fast results. For
instance, in November 2016, Radiometer introduced ABL9 blood gas
analyzer to hospital settings, including point-of-care (PoC), lab and
specialized wards, and primary care settings, in Japan, France, Turkey
and Germany.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2603
Moreover, in 2015, Sphere Medical launched arterial blood gas analyzer–
Proxima System in Germany, the Netherlands, and Belgium at ISICEM 2015.
The device delivers efficient PoC testing as it offers frequent blood
gas measurements. This facilitates effective and timely clinical
decisions for proactive critical care.
North America blood gas analyzers market is expected to generate
significant revenue share during the forecast period, owing to
increasing prevalence of lifestyle-induced diseases and high emergency
department visits. According to the Centers for Disease Control and
Prevention (CDC) report, in 2017, around 1.7 million emergency
department visits with chronic and unspecified bronchitis were recorded
in the U.S.
To know the latest trends and insights prevalent in this market,
click the link below:
https://www.coherentmarketinsights.com/market-insight/blood-gas-analyzers-market-2603
Key Market Takeaways:
-
The global blood gas analyzers market is expected to exhibit a CAGR of
5.5% during the forecast period (2018 – 2026). This is attributed to
increasing geriatric population that is highly susceptible to various
chronic diseases. According to the U.S. Census Bureau, 2015, the
number of people aged 65 years and above is expected to increase over
60% during 2015 – 2030 in the U.S. -
Key market players are focused on developing portable blood gas
analyzers in order to increase usability and comfort of the analyzers.
For instance, in April 2018, Radiometer Limited launched its CE-marked
point-of-care tests for creatinine and urea, which is the latest
additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu. The
versatile ABL90 FLEX PLUS is considered to be the only compact blood
gas analyzer in the market to offer such an extensive range of
critical care parameters including blood gas, electrolytes,
metabolites, and co-oximetry. -
Key players operating in the global blood gas analyzers market
include, Abbott Laboratories, Alere, Inc., Bayer AG, Dalko
Diagnostics, GE Healthcare, Instrumentation Laboratory, Nova
Biomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and
Sphere Medical
Buy this exclusive Business report now @ https://www.coherentmarketinsights.com/insight/buy-now/2603
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting
firm offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contacts
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle,
WA 98154
Tel: +1-206-701-6702
Email: [email protected]
